Adenosine Receptors in Neurology and Psychiatry
Volume 119
Herausgegeben:Mori, Akihisa
Adenosine Receptors in Neurology and Psychiatry
Volume 119
Herausgegeben:Mori, Akihisa
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This well-established international series examines major areas of basic and clinical research within neuroscience, as well as emerging and promising subfields. This volume concentrates on adenosine receptor science, providing insights useful for actual drug discovery/development in neurology and psychiatry areas.
Andere Kunden interessierten sich auch für
- Curcumin for Neurological and Psychiatric Disorders97,99 €
- Andreas GrabruckerBiometals in Autism Spectrum Disorders97,99 €
- Aamir Saeed MalikDesigning Eeg Experiments for Studying the Brain65,99 €
- Brain Edema80,99 €
- Z Score Neurofeedback82,99 €
- Brain Transcriptome117,99 €
- Catecholamine Research in the 21st Century30,99 €
-
-
-
This well-established international series examines major areas of basic and clinical research within neuroscience, as well as emerging and promising subfields. This volume concentrates on adenosine receptor science, providing insights useful for actual drug discovery/development in neurology and psychiatry areas.
Produktdetails
- Produktdetails
- International Review of Neurobiology Volume 119
- Verlag: Academic Press / Elsevier Science & Technology
- Artikelnr. des Verlages: C2013-0-12893-0
- Seitenzahl: 524
- Erscheinungstermin: 2. September 2014
- Englisch
- Abmessung: 231mm x 155mm x 30mm
- Gewicht: 910g
- ISBN-13: 9780128010228
- ISBN-10: 0128010223
- Artikelnr.: 41250831
- International Review of Neurobiology Volume 119
- Verlag: Academic Press / Elsevier Science & Technology
- Artikelnr. des Verlages: C2013-0-12893-0
- Seitenzahl: 524
- Erscheinungstermin: 2. September 2014
- Englisch
- Abmessung: 231mm x 155mm x 30mm
- Gewicht: 910g
- ISBN-13: 9780128010228
- ISBN-10: 0128010223
- Artikelnr.: 41250831
Akihisa Mori, PhD., Deputy Director, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd. Tokyo, Japan. He has been leading adenosine A2A receptor science, intensively and extensively researching and discovering physiological functions of adenosine A2A receptor for brain motor control, and through such a tremendous scientific work, has also been working for a first-in-class Adenosine A2A receptor antagonist as new medication for Parkinson's Disease, for more than 20 years, from its discovery stage to filing both US and Japan NDA, which has been launched in Japan (2013). He was graduated from Faculty of Pharmaceutical Sciences, Kyoto University in 1985, and obtained Ph.D. degree from Graduate School of Medicine and Faculty of Medicine, The University of Tokyo in 1996. With number of publications in peer review journals in neuroscience field (e.g., J. Neuroscience, Neurology, J. Physiology, Annals of Neurology, British J Pharmacology etc.), he has given more than 20 l
ectures/podium talks for academia/universities and international conferences on various subjects (e.g., neurophysiology, adenosine receptor science, Parkinson's Disease, global drug development etc.) held not only in Japan but also in UK, Germany, Australia, Austria, and USA. In summary, he has greatly been contributing to translate from basic science of adenosine biology to practical drug development for adenosine receptor ligand in neurology area.
ectures/podium talks for academia/universities and international conferences on various subjects (e.g., neurophysiology, adenosine receptor science, Parkinson's Disease, global drug development etc.) held not only in Japan but also in UK, Germany, Australia, Austria, and USA. In summary, he has greatly been contributing to translate from basic science of adenosine biology to practical drug development for adenosine receptor ligand in neurology area.
- Adenosine Receptor Neurobiology: Overview
- Adenosine Receptor PET Imaging in Human Brain
- An Overview of Adenosine A2A Receptor Antagonists in Parkinson's Disease
- Mode of Action of Adenosine A2A Receptor Antagonists as Symptomatic Treatment for Parkinson's Disease
- Adenosine Receptors and Dyskinesia in Pathophysiology
- Clinical/Pharmacological Aspect of Adenosine A2A Receptor Antagonist for Dyskinesia
- Interaction of Adenosine Receptors With Other Receptors from Therapeutic Perspective in Parkinson's Disease
- Effects of the Adenosine A2A Receptor Antagonist on Cognitive Dysfunction in Parkinson's Disease
- Clinical Non-Motor Aspect of A2A Antagonist in PD Treatment
- Adenosine Receptors and Huntington's Disease
- Adenosine Receptors and Epilepsy: Established Evidence and Perennial Potential
- Adenosine Receptor Control of Cognition in Normal and Disease
- Adenosine Receptors in Cerebral Ischemia
- Roles of Adenosine and its Receptors in Sleep-Wake Regulation
- Involvement of Adenosine A2A Receptors in Depression and Anxiety
- The Adenosine Neuromodulation System in SchizophreniaDaniel Rial, Diogo R. Lara and Rodrigo A. Cunha
Jiang-Fan Chen, Chien-fei Lee and Yijuang Chern
Masahiro Mishina and Kiich Ishiwata
Peter Jenner
Akihisa Mori
Masahiko Tomiyama
Tomoyuki Kanda and Shin-ichi Uchida
Nicolas Morin and Thérèse Di Paolo
Shin-ichi Uchida, Takako Kadowaki-Horita and Tomoyuki Kanda
Masahiro Nomoto, Masahiro Nagai and Noriko Nishikawa
Chien-fei Lee and Yijuang Chern
Susan A. Masino, Masahito Kawamura, Jr. and David N. Ruskin
Jiang-Fan Chen
Alessia Melani, Anna Maria Pugliese, and Felicita Pedata
Zhi-Li Huang, Ze Zheng and Wei-Min Qu
Koji Yamada, Minoru Kobayashi and Tomoyuki Kanda
- Adenosine Receptor Neurobiology: Overview
- Adenosine Receptor PET Imaging in Human Brain
- An Overview of Adenosine A2A Receptor Antagonists in Parkinson's Disease
- Mode of Action of Adenosine A2A Receptor Antagonists as Symptomatic Treatment for Parkinson's Disease
- Adenosine Receptors and Dyskinesia in Pathophysiology
- Clinical/Pharmacological Aspect of Adenosine A2A Receptor Antagonist for Dyskinesia
- Interaction of Adenosine Receptors With Other Receptors from Therapeutic Perspective in Parkinson's Disease
- Effects of the Adenosine A2A Receptor Antagonist on Cognitive Dysfunction in Parkinson's Disease
- Clinical Non-Motor Aspect of A2A Antagonist in PD Treatment
- Adenosine Receptors and Huntington's Disease
- Adenosine Receptors and Epilepsy: Established Evidence and Perennial Potential
- Adenosine Receptor Control of Cognition in Normal and Disease
- Adenosine Receptors in Cerebral Ischemia
- Roles of Adenosine and its Receptors in Sleep-Wake Regulation
- Involvement of Adenosine A2A Receptors in Depression and Anxiety
- The Adenosine Neuromodulation System in SchizophreniaDaniel Rial, Diogo R. Lara and Rodrigo A. Cunha
Jiang-Fan Chen, Chien-fei Lee and Yijuang Chern
Masahiro Mishina and Kiich Ishiwata
Peter Jenner
Akihisa Mori
Masahiko Tomiyama
Tomoyuki Kanda and Shin-ichi Uchida
Nicolas Morin and Thérèse Di Paolo
Shin-ichi Uchida, Takako Kadowaki-Horita and Tomoyuki Kanda
Masahiro Nomoto, Masahiro Nagai and Noriko Nishikawa
Chien-fei Lee and Yijuang Chern
Susan A. Masino, Masahito Kawamura, Jr. and David N. Ruskin
Jiang-Fan Chen
Alessia Melani, Anna Maria Pugliese, and Felicita Pedata
Zhi-Li Huang, Ze Zheng and Wei-Min Qu
Koji Yamada, Minoru Kobayashi and Tomoyuki Kanda